Four non-stimulant medications are currently FDA-approved to treat ADHD: atomoxetine (Strattera), viloxazine (Qelbree), guanfacine (Intuniv), and clonidine (Kapvay). These drugs work differently from stimulants like Adderall or Ritalin, take longer to kick in, and are generally less potent, but they fill an important role for people who can’t tolerate stimulants or have reasons to avoid them. A fifth option, bupropion (Wellbutrin), is sometimes prescribed off-label.
The Two Categories of Non-Stimulants
Non-stimulant ADHD medications fall into two groups based on how they work in the brain. Understanding the difference helps explain why your doctor might recommend one type over the other.
Norepinephrine-targeting medications (atomoxetine and viloxazine) work by increasing the availability of norepinephrine, a chemical messenger involved in attention and executive function. Atomoxetine blocks the recycling of norepinephrine so more of it stays active between brain cells. Viloxazine does the same thing but also influences serotonin activity, which may give it a slightly different side effect profile.
Alpha-2 agonists (guanfacine and clonidine) were originally developed to treat high blood pressure. They work by strengthening signaling in the prefrontal cortex, the part of the brain responsible for focus, impulse control, and planning. Guanfacine in particular enhances the connectivity between brain cells in this region, improving what researchers call “top-down control,” your ability to override distractions and regulate behavior.
How They Compare to Stimulants
Stimulants remain the first-line treatment for ADHD because they work faster and produce larger symptom improvements on average. In network meta-analyses comparing drug classes, amphetamines and methylphenidate consistently outperform non-stimulants on clinician-rated symptom scales. In children, amphetamines showed roughly twice the effect size of atomoxetine. In adults, the gap was smaller but still meaningful.
That said, the picture is more nuanced than “stimulants are better.” When researchers looked at long-term cognitive effects rather than just symptom ratings, atomoxetine actually showed medium-to-large improvements across several thinking skills, comparable to or slightly exceeding methylphenidate, except in working memory, where it showed no benefit. So non-stimulants may hold their own over time in ways that short-term studies don’t capture.
Why People Choose Non-Stimulants
There are several practical reasons a non-stimulant might be the better fit:
- Anxiety: Stimulants can worsen anxiety symptoms. Atomoxetine in particular may be helpful for people who have both ADHD and anxiety.
- Tic disorders: Alpha-2 agonists like guanfacine and clonidine are often preferred when ADHD coexists with tics or Tourette syndrome, since stimulants can sometimes aggravate tics.
- Substance use concerns: Non-stimulants have no abuse potential. Some families choose them specifically to avoid having a controlled substance in the house.
- Appetite and weight loss: Stimulants commonly suppress appetite. Guanfacine doesn’t have much effect on appetite, making it a reasonable option when weight loss on stimulants has been a problem.
- Sleep problems: Alpha-2 agonists can actually promote drowsiness, which may be a benefit for people whose ADHD comes with significant insomnia.
- Failed stimulant trials: Atomoxetine is often used when one or more stimulants have been tried without adequate results or with intolerable side effects.
How Long They Take to Work
This is the biggest adjustment for people switching from stimulants. Stimulant medications work within an hour or two of the first dose. Non-stimulants take three to four weeks of daily use before you feel the full effect. That waiting period can be frustrating, especially if you’re used to the immediate clarity a stimulant provides. Doses are typically started low and increased gradually over several weeks, which stretches the timeline further.
Viloxazine, for example, starts at 100 to 200 mg daily depending on age, and can be titrated up weekly to a maximum of 400 mg in children or 600 mg in adults. This means it may take a month or more of adjustments before you and your doctor land on the right dose.
Side Effects to Expect
Each category comes with its own side effect profile, and they feel quite different from the jitteriness or appetite loss common with stimulants.
Atomoxetine and Viloxazine
The most common complaints are nausea, decreased appetite (though less than with stimulants), and fatigue. Atomoxetine carries two significant safety warnings. The FDA requires a boxed warning about increased risk of suicidal thinking in children and adolescents, particularly during the first few months of treatment or when doses change. It can also, in rare cases, cause serious liver injury. Signs to watch for include yellowing of the skin or eyes, dark urine, unexplained flu-like symptoms, or pain in the upper right side of the abdomen. Atomoxetine has also been linked in rare instances to new onset of hallucinations, manic symptoms, or increased aggression, even in people with no prior psychiatric history beyond ADHD.
Guanfacine and Clonidine
Because these drugs were designed to lower blood pressure, their side effects reflect that. Drowsiness and fatigue are the most common, sometimes significant enough that doses are given at bedtime. Dizziness when standing up quickly is also typical, especially early on. Less commonly, people experience slow heart rate or, paradoxically, a fast or irregular heartbeat. These medications should never be stopped abruptly, as doing so can cause a rebound spike in blood pressure.
Bupropion as an Off-Label Option
Bupropion, better known as the antidepressant Wellbutrin, is not FDA-approved for ADHD but is sometimes prescribed for it in adults. A Cochrane review found that it modestly reduces ADHD symptom severity and that adults taking it were about 50% more likely to experience clinical improvement compared to placebo. However, the evidence quality is low, and the review’s authors noted that further research could substantially change those estimates. Bupropion is most commonly considered when someone has both ADHD and depression, since it can address both conditions with a single medication.
Using Non-Stimulants Alongside Stimulants
Non-stimulants don’t have to be an either-or choice. Alpha-2 agonists in particular are frequently prescribed as add-ons to a stimulant. This combination can help manage symptoms that a stimulant alone doesn’t fully cover, like impulsivity, aggression, or difficulty falling asleep at night. The combination of a stimulant for core attention symptoms plus guanfacine or clonidine for behavioral regulation and sleep is one of the more common multi-drug approaches in ADHD treatment.